{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:37:38Z","timestamp":1785148658000,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Whey protein concentrate (WPC) is an amino acid-rich supplement that has been shown to increase cellular antioxidant capacity. Mammalian target of rapamycin (mTOR) is a crucial regulator of signaling in mammalian cells, and serves as a therapeutic target for triple-negative breast cancer (TNBC). This study was designed to investigate the effect of combining WPC with rapamycin on MDA-MB-231 human breast cancer cells. These cells were found to be insensitive to rapamycin and exhibited higher glutathione (GSH) and reactive oxygen species levels than non-tumorigenic MCF-10A cells. However, for MDA-MB-231 cells, the half maximal inhibitory concentration of rapamycin was lower when this drug was administered in combination with WPC than when used alone. Furthermore, combining WPC with rapamycin depleted GSH levels and reduced Nrf2 nuclear accumulation. In addition, WPC activated GSK3\u03b2\/mTOR signaling, and GSK3\u03b2 appeared to be involved in the WPC-mediated Nrf2 reduction and mTOR activation. In conclusion, WPC induced rapamycin sensitivity in MDA-MB-231 cells by altering their redox state and activating GSK3\u03b2\/mTOR signaling. These results not only suggest a novel therapeutic approach for breast cancer treatment, but also provide insight into the critical pathways affecting the resistance to mTOR inhibition observed in a subgroup of TNBC patients.<\/jats:p>","DOI":"10.1038\/s41598-017-14159-5","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T16:48:18Z","timestamp":1510764498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Whey Protein Concentrate Renders MDA-MB-231 Cells Sensitive to Rapamycin by Altering Cellular Redox State and Activating GSK3\u03b2\/mTOR Signaling"],"prefix":"10.1038","volume":"7","author":[{"given":"Shih-Hsuan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ming","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Hsien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Meng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"14159_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. N Engl J Med \n                           363, 1938\u20131948, https:\/\/doi.org\/10.1056\/NEJMra1001389 (2010).","journal-title":"N Engl J Med"},{"key":"14159_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","volume":"40","author":"S Sengupta","year":"2010","unstructured":"Sengupta, S., Peterson, T. R. & Sabatini, D. M. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell \n                           40, 310\u2013322, https:\/\/doi.org\/10.1016\/j.molcel.2010.09.026 (2010).","journal-title":"Mol Cell"},{"key":"14159_CR3","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1038\/onc.2014.390","volume":"34","author":"I Azoulay-Alfaguter","year":"2015","unstructured":"Azoulay-Alfaguter, I., Elya, R., Avrahami, L., Katz, A. & Eldar-Finkelman, H. Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth. Oncogene \n                           34, 4613\u20134623, https:\/\/doi.org\/10.1038\/onc.2014.390 (2015).","journal-title":"Oncogene"},{"key":"14159_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/BJ20150404","volume":"470","author":"C Stretton","year":"2015","unstructured":"Stretton, C. et al. GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling. Biochem J \n                           470, 207\u2013221, https:\/\/doi.org\/10.1042\/bj20150404 (2015).","journal-title":"Biochem J"},{"key":"14159_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic Res \n                           44, 479\u2013496, https:\/\/doi.org\/10.3109\/10715761003667554 (2010).","journal-title":"Free Radic Res"},{"key":"14159_CR6","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative stress. Current biology: CB \n                           24, R453\u2013462, https:\/\/doi.org\/10.1016\/j.cub.2014.03.034 (2014).","journal-title":"Current biology: CB"},{"key":"14159_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.taap.2009.08.018","volume":"244","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q., Pi, J., Woods, C. G. & Andersen, M. E. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol \n                           244, 84\u201397, https:\/\/doi.org\/10.1016\/j.taap.2009.08.018 (2010).","journal-title":"Toxicol Appl Pharmacol"},{"key":"14159_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","volume":"66","author":"SK Niture","year":"2014","unstructured":"Niture, S. K., Khatri, R. & Jaiswal, A. K. Regulation of Nrf2-an update. Free Radic Biol Med \n                           66, 36\u201344, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.02.008 (2014).","journal-title":"Free Radic Biol Med"},{"key":"14159_CR9","doi-asserted-by":"publisher","unstructured":"Owonikoko, T. K. & Khuri, F. R. Targeting the PI3K\/AKT\/mTOR pathway: biomarkers of success and tribulation. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, https:\/\/doi.org\/10.1200\/EdBook_AM.2013.33.e395 (2013).","DOI":"10.1200\/EdBook_AM.2013.33.e395"},{"key":"14159_CR10","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1101\/gad.225680.113","volume":"27","author":"MC Jaramillo","year":"2013","unstructured":"Jaramillo, M. C. & Zhang, D. D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev \n                           27, 2179\u20132191, https:\/\/doi.org\/10.1101\/gad.225680.113 (2013).","journal-title":"Genes Dev"},{"key":"14159_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1758834014530023","volume":"6","author":"E Paplomata","year":"2014","unstructured":"Paplomata, E. & O\u2019Regan, R. The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers. Therapeutic advances in medical oncology \n                           6, 154\u2013166, https:\/\/doi.org\/10.1177\/1758834014530023 (2014).","journal-title":"Therapeutic advances in medical oncology"},{"key":"14159_CR12","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.18632\/oncotarget.2209","volume":"5","author":"NM Davis","year":"2014","unstructured":"Davis, N. M. et al. Deregulation of the EGFR\/PI3K\/PTEN\/Akt\/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget \n                           5, 4603\u20134650, https:\/\/doi.org\/10.18632\/oncotarget.2209 (2014).","journal-title":"Oncotarget"},{"key":"14159_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3760\/cma.j.issn.0253-3766.2016.08.004","volume":"38","author":"WL Zhang","year":"2016","unstructured":"Zhang, W. L. et al. Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells. Zhonghua zhong liu za zhi [Chinese journal of oncology] \n                           38, 578\u2013588, https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3766.2016.08.004 (2016).","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"key":"14159_CR14","doi-asserted-by":"publisher","first-page":"12729","DOI":"10.1021\/jf103518u","volume":"58","author":"YM Tseng","year":"2010","unstructured":"Tseng, Y. M. et al. Effects of whey protein concentrate (WPC) on the distributions of lymphocyte subpopulations in rats with excessive alcohol intake. J Agric Food Chem \n                           58, 12729\u201312734, https:\/\/doi.org\/10.1021\/jf103518u (2010).","journal-title":"J Agric Food Chem"},{"key":"14159_CR15","doi-asserted-by":"publisher","unstructured":"Tseng, Y. M. et al. Effects of alcohol-induced human peripheral blood mononuclear cell (PBMC) pretreated whey protein concentrate (WPC) on oxidative damage. J Agric Food Chem \n                           56, 8141\u20138147, https:\/\/doi.org\/10.1021\/jf801034k (2008).","DOI":"10.1021\/jf801034k"},{"key":"14159_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.fct.2017.07.024","volume":"107","author":"SH Cheng","year":"2017","unstructured":"Cheng, S. H., Tseng, Y. M., Wu, S. H., Tsai, S. M. & Tsai, L. Y. Selective effects of whey protein concentrate on glutathione levels and apoptosis in rats with mammary tumors. Food Chem Toxicol \n                           107, 440\u2013448, https:\/\/doi.org\/10.1016\/j.fct.2017.07.024 (2017).","journal-title":"Food Chem Toxicol"},{"key":"14159_CR17","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.3390\/nu7105420","volume":"7","author":"CJ Mitchell","year":"2015","unstructured":"Mitchell, C. J. et al. Consumption of Milk Protein or Whey Protein Results in a Similar Increase in Muscle Protein Synthesis in Middle Aged Men. Nutrients \n                           7, 8685\u20138699, https:\/\/doi.org\/10.3390\/nu7105420 (2015).","journal-title":"Nutrients"},{"key":"14159_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.fct.2016.08.022","volume":"97","author":"E Kerasioti","year":"2016","unstructured":"Kerasioti, E., Stagos, D., Tzimi, A. & Kouretas, D. Increase in antioxidant activity by sheep\/goat whey protein through nuclear factor-like 2 (Nrf2) is cell type dependent. Food Chem Toxicol \n                           97, 47\u201356, https:\/\/doi.org\/10.1016\/j.fct.2016.08.022 (2016).","journal-title":"Food Chem Toxicol"},{"key":"14159_CR19","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest \n                           121, 2750\u20132767, https:\/\/doi.org\/10.1172\/jci45014 (2011).","journal-title":"J Clin Invest"},{"key":"14159_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-03-0043","volume":"10","author":"WC Noh","year":"2004","unstructured":"Noh, W. C. et al. Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res \n                           10, 1013\u20131023 (2004).","journal-title":"Clin Cancer Res"},{"key":"14159_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1200\/JCO.2007.14.5375","volume":"26","author":"HJ Burstein","year":"2008","unstructured":"Burstein, H. J. et al. Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol \n                           26, 1810\u20131816, https:\/\/doi.org\/10.1200\/jco.2007.14.5375 (2008).","journal-title":"J Clin Oncol"},{"key":"14159_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14084","author":"K Manupati","year":"2017","unstructured":"Manupati, K. et al. Inhibiting Epidermal Growth Factor Receptor Signalling Potentiates Mesenchymal-Epithelial Transition of Breast Cancer Stem Cells and their Responsiveness to Anticancer Drugs. Febs j. https:\/\/doi.org\/10.1111\/febs.14084 (2017).","journal-title":"Febs j"},{"key":"14159_CR23","doi-asserted-by":"publisher","unstructured":"Dey, N., De, P. & Leyland-Jones, B. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials. Pharmacology & therapeutics, https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.037 (2017).","DOI":"10.1016\/j.pharmthera.2017.02.037"},{"key":"14159_CR24","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1200\/JCO.2010.34.4879","volume":"29","author":"TW Miller","year":"2011","unstructured":"Miller, T. W., Balko, J. M. & Arteaga, C. L. Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer. J Clin Oncol \n                           29, 4452\u20134461, https:\/\/doi.org\/10.1200\/jco.2010.34.4879 (2011).","journal-title":"J Clin Oncol"},{"key":"14159_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000358365","volume":"88","author":"D Kim","year":"2015","unstructured":"Kim, D., Koo, J. S. & Lee, S. Overexpression of reactive oxygen species scavenger enzymes is associated with a good prognosis in triple-negative breast cancer. Oncology \n                           88, 9\u201317, https:\/\/doi.org\/10.1159\/000358365 (2015).","journal-title":"Oncology"},{"key":"14159_CR26","doi-asserted-by":"publisher","first-page":"32651","DOI":"10.1074\/jbc.M111.238014","volume":"286","author":"S Yoshida","year":"2011","unstructured":"Yoshida, S. et al. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1\/TSC2-Rheb GTPase pathway. J Biol Chem \n                           286, 32651\u201332660, https:\/\/doi.org\/10.1074\/jbc.M111.238014 (2011).","journal-title":"J Biol Chem"},{"key":"14159_CR27","doi-asserted-by":"publisher","first-page":"39505","DOI":"10.1074\/jbc.M506096200","volume":"280","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D. & Sabatini, D. M. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J Biol Chem \n                           280, 39505\u201339509, https:\/\/doi.org\/10.1074\/jbc.M506096200 (2005).","journal-title":"J Biol Chem"},{"key":"14159_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cbf.1275","volume":"24","author":"CC Yeh","year":"2006","unstructured":"Yeh, C. C. et al. A study of glutathione status in the blood and tissues of patients with breast cancer. Cell Biochem Funct \n                           24, 555\u2013559, https:\/\/doi.org\/10.1002\/cbf.1275 (2006).","journal-title":"Cell Biochem Funct"},{"key":"14159_CR29","doi-asserted-by":"publisher","first-page":"6429812","DOI":"10.1155\/2016\/6429812","volume":"2015","author":"C Panis","year":"2015","unstructured":"Panis, C. et al. Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, andPlasma. Oxidative medicine and cellular longevity \n                           2015, 6429812, https:\/\/doi.org\/10.1155\/2016\/6429812 (2015).","journal-title":"Oxidative medicine and cellular longevity"},{"key":"14159_CR30","first-page":"136","volume":"9","author":"K Marshall","year":"2004","unstructured":"Marshall, K. Therapeutic applications of whey protein. Alternative medicine review: a journal of clinical therapeutic \n                           9, 136\u2013156 (2004).","journal-title":"Alternative medicine review: a journal of clinical therapeutic"},{"key":"14159_CR31","first-page":"4785","volume":"20","author":"G Bounous","year":"2000","unstructured":"Bounous, G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res \n                           20, 4785\u20134792 (2000).","journal-title":"Anticancer Res"},{"key":"14159_CR32","doi-asserted-by":"crossref","first-page":"19675","DOI":"10.1016\/S0021-9258(19)36569-X","volume":"268","author":"CS Huang","year":"1993","unstructured":"Huang, C. S., Chang, L. S., Anderson, M. E. & Meister, A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem \n                           268, 19675\u201319680 (1993).","journal-title":"J Biol Chem"},{"key":"14159_CR33","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00280-010-1417-7","volume":"67","author":"M Suzuki","year":"2011","unstructured":"Suzuki, M., Endo, M., Shinohara, F., Echigo, S. & Rikiishi, H. Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells. Cancer Chemother Pharmacol \n                           67, 1129\u20131136, https:\/\/doi.org\/10.1007\/s00280-010-1417-7 (2011).","journal-title":"Cancer Chemother Pharmacol"},{"key":"14159_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.redox.2016.09.006","volume":"10","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer. Redox biology \n                           10, 78\u201389, https:\/\/doi.org\/10.1016\/j.redox.2016.09.006 (2016).","journal-title":"Redox biology"},{"key":"14159_CR35","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.4161\/cc.10.22.18124","volume":"10","author":"P Yellen","year":"2011","unstructured":"Yellen, P. et al. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. Cell Cycle \n                           10, 3948\u20133956, https:\/\/doi.org\/10.4161\/cc.10.22.18124 (2011).","journal-title":"Cell Cycle"},{"key":"14159_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4837","volume":"5","author":"S Miwa","year":"2014","unstructured":"Miwa, S. et al. Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice. Nature communications \n                           5, 3837, https:\/\/doi.org\/10.1038\/ncomms4837 (2014).","journal-title":"Nature communications"},{"key":"14159_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bcp.2014.07.017","volume":"92","author":"A Glasauer","year":"2014","unstructured":"Glasauer, A. & Chandel, N. S. Targeting antioxidants for cancer therapy. Biochem Pharmacol \n                           92, 90\u2013101, https:\/\/doi.org\/10.1016\/j.bcp.2014.07.017 (2014).","journal-title":"Biochem Pharmacol"},{"key":"14159_CR38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola, G. M. et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature \n                           475, 106\u2013109, https:\/\/doi.org\/10.1038\/nature10189 (2011).","journal-title":"Nature"},{"key":"14159_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2012.04.007","volume":"15","author":"S Robida-Stubbs","year":"2012","unstructured":"Robida-Stubbs, S. et al. TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO. Cell metabolism \n                           15, 713\u2013724, https:\/\/doi.org\/10.1016\/j.cmet.2012.04.007 (2012).","journal-title":"Cell metabolism"},{"key":"14159_CR40","doi-asserted-by":"publisher","first-page":"e0132376","DOI":"10.1371\/journal.pone.0132376","volume":"10","author":"P Calap-Quintana","year":"2015","unstructured":"Calap-Quintana, P. et al. TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich\u2019s Ataxia. PLoS One \n                           10, e0132376, https:\/\/doi.org\/10.1371\/journal.pone.0132376 (2015).","journal-title":"PLoS One"},{"key":"14159_CR41","doi-asserted-by":"publisher","unstructured":"Faes, S., Demartines, N. & Dormond, O. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. 2017, 1726078, https:\/\/doi.org\/10.1155\/2017\/1726078 (2017).","DOI":"10.1155\/2017\/1726078"},{"key":"14159_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak, Y. et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell \n                           141, 290\u2013303, https:\/\/doi.org\/10.1016\/j.cell.2010.02.024 (2010).","journal-title":"Cell"},{"key":"14159_CR43","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science \n                           320, 1496\u20131501, https:\/\/doi.org\/10.1126\/science.1157535 (2008).","journal-title":"Science"},{"key":"14159_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1471-4159.2007.05124.x","volume":"105","author":"AI Rojo","year":"2008","unstructured":"Rojo, A. I., Sagarra, M. R. & Cuadrado, A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem \n                           105, 192\u2013202, https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05124.x (2008).","journal-title":"J Neurochem"},{"key":"14159_CR45","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","volume":"17","author":"E Schreiber","year":"1989","unstructured":"Schreiber, E., Matthias, P., Muller, M. M. & Schaffner, W. Rapid detection of octamer binding proteins with \u2018mini-extracts\u2019, prepared from a small number of cells. Nucleic acids research \n                           17, 6419 (1989).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14159-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14159-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:51:27Z","timestamp":1671803487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14159-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14159-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"assertion":[{"value":"6 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15976"}}